MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » JenaValve taps medtech vet Keltjens for interim CEO | Personnel Moves

JenaValve taps medtech vet Keltjens for interim CEO | Personnel Moves

By

JenaValve taps medtech vet Keltjens for interim CEO | Personnel Moves

JenaValve tapped a medtech veteran with a string of successful exits behind him as interim chairman & CEO, replacing another medical device vet, David Drachman, after just 7 months.

Drachman, who spent 10 years in the corner office at AtriCure (NSDQ:ATRC), "resigned from the company for non-business related personal reasons, JenaValve said.

JenaValve, which makes a transcatheter aortic valve implant that’s on the market in Europe, had named Drachman to be its new CEO last July.

Keltjens has a long pedigree in the medical device space. Formerly the chief executive at AngioDynamics (NSDQ:ANGO), he took over at Endosense and led it to a $331 million acquisition by St. Jude Medical (NYSE:STJ). By October 2013 Keltjens had landed at Sapiens Brain Steering Stimulation, which Medtronic (NYSE:MDT) acquired for $200 million less than a year later. He’s been a director at Munich- and Irvine, Calif.-based JenaValve since January 2014, according to the company’s website.

"I would like to thank Dave Drachman for his many valuable contributions to JenaValve over the past 6 months. It is unfortunate that his personal circumstances led him to resign his position. We sincerely wish Dave all the best for his future. As interim CEO, I will work closely with the leadership team to ensure that we maintain momentum and continue to drive our company forward while we search for a new U.S.-based chief executive," Keltjens said in prepared remarks. "In the past 6 months, we have made great progress in finalizing the design and testing of our next-generation pericardial valve platform. Moreover, we have worked closely with the regulatory agencies in both the U.S. and the European Union to define clear clinical and regulatory pathways. I am confident in our future based on great technology, strong teams in Munich and Irvine and the TAVI market being one of the fastest growth opportunities in medical devices as well as unwavering support from our board and shareholders."

 Brigham & Women’s president Nabel is NFL’s 1st medical chief

The National Football League yesterday named Dr. Elizabeth Nabel, president of Boston’s Brigham & Women’s Hospital, to be its 1st chief health & medical advisor. The Brigham also tapped chief quality officer Dr. David Bates to be its chief innovation officer.
Read more

 Inari Medical taps ex-Visualase CEO Hoffman
Inari Medical said it named ex-Visualase chief Bill Hoffman to be its new president & CEO. Medtronic acquired Visualase for $105 million last year.
Read more

 Intersect ENT names McKhann as CCOY
Intersect ENT (NSDQ:XENT) said it named Chas McKhann, a longtime exec at Johnson & Johnson‘s (NYSE:JNJ) Cordis unit and then at Boston Scientific (NYSE:BSX), to be its new chief commercial officer.
Read more

 Biolase CFO Furry is out

Biolase (NSDQ:BIOL) said CFO Frederick Furry resigned effective Jan. 31 "to pursue other opportunities."
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • The 24 best medical device innovations of 2022
    The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products designed to improve the human condition.… […]
  • FDA issues new COVID-19 testing guidance to avoid false negatives
    COVID-19 testing should be repeated following a negative result on any antigen test, the FDA said in a move that could increase demand for diagnostics manufacturers. The latest guidance from the federal health agency is for negative COVID-19 antigen test results regardless of the presence or absence of symptoms. The federal agency said recent studies… […]
  • Confluent Medical expands Costa Rica manufacturing footprint for nitinol, complex catheter production
    Confluent Medical Technologies this week announced the opening of its new addition to its Costa Rica manufacturing facility. The expansion adds 66,000 sq. ft to its large-scale manufacturing center of excellence in Alajuela, Costa Rica to expand Confluent’s capacity for nitinol component processing and complex catheter manufacturing. “Confluent has experienced consistent and strong growth in… […]
  • FDA’s breakthrough medical device designations tally nears 700
    Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted almost 700 designations over the past seven years under a voluntary program for expedited regulatory review of medical devices and combination products that facilitate more effective treatment or diagnosis of serious diseases. According to recent metrics published by FDA, the agency has issued a total of… […]
  • Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing
    Lifecore Biomedical parent company Landec Corp. (Nasdaq:LNDC) plans to take the subsidiary’s name, leadership and headquarters as its own and sell off food businesses to focus on contract development and manufacturing. Santa Maria, California-based Landec said it will rename itself as Lifecore Biomedical “in the near future” and change its Nasdaq ticker to LFCR. Landec… […]
  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]
  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]
  • 5 essential leadership lessons from Cathy Burzik for medtech’s next generation of women leaders
    Cathy Burzik, a seasoned senior executive in the healthcare industry, has successfully led major medical device, diagnostic, diagnostic imaging and life sciences businesses. Cathy Burzik, CFB Interests (as told to MedExecWomen co-founder Maria Shepherd) One key to being a successful women leader in MedTech: “Play nice, but play to win.” Cathy Burzik, who received a… […]
  • Stratasys plans to buy Covestro’s additive manufacturing business
    Stratasys (Nasdaq:SSYS) said today that it has a deal to purchase the additive manufacturing materials business of Covestro. The deal includes R&D facilities and activities, global development and sales teams across Europe, the U.S. and China, a portfolio of approximately 60 additive manufacturing materials, and hundreds of patents and patents pending, Stratasys said in a… […]
  • New implant design prevents scar tissue without drugs, MIT says
    Mechanically inflating and deflating an implantable device for 10 minutes a day prevents immune cells from building the scar tissue that has been a major obstacle for artificial pancreas researchers. That’s according to new findings from a team of MIT engineers who built mechanical deflection into a two-chambered, soft polyurethane device tested on mice. By… […]

Leave a Reply